14 July 2017
Karlsruhe
Reporter: Mark Dugdale

Top German court backs compulsory licence


A German court was right to grant a compulsory licence to a patent for a HIV drug, the country’s Federal Court of Justice has ruled.

Germany’s Federal Court of Justice this week upheld a Federal Patent Court decision to grant an injunction ordering the issuance of a compulsory licence to the European patent protecting the underlying compound in Isentress, an anti-viral that treats HIV.

Japanese pharmaceutical company Shionogi owns a family of patents to the raltegravir compound in Isentress.

Merck manufactures and sells Isentress in Europe, but has been unable to agree a worldwide licence with Shionogi for its raltegravir patents, prompting the litigation.

The Federal Court of Justice backed the Federal Patent Court’s decision to force through a compulsory licence, as Merck had made sufficient attempts to negotiate a licence.

There was also significant public interest in keeping access to Isentress open in Germany, where it is the only anti-viral containing raltegravir available and is required to meet the needs of certain patients, including infants, pregnant women, and people who have already been prescribed with Isentress.

Compulsory licences are not granted often, in Europe or globally.

Rwanda and Thailand have issued compulsory licences in the past. In 2012, the Indian government granted a compulsory licence to Natco Pharma to manufacture and distribute Nexavar for 3 percent of the cost of the original drug patented by Bayer, although the licence was eventually revoked.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Baker Botts promotes three in IP
21 November 2017 | Texas | Reporter: Barney Dixon
Baker Botts has promoted three intellectual property attorneys to partner, as part of a round of 11 partner promotions
Alibaba in ITC spotlight
20 November 2017 | Washington DC | Reporter: Barney Dixon
Alibaba will be investigated by the US International Trade Commission over the importation and sale of insulated beverage containers, their labels, and packaging materials
MediaTek partners with Anaqua
20 November 2017 | Boston | Reporter: Barney Dixon
Taiwanese semiconductor company MediaTek has selected Anaqua to manage its intellectual property activities, including its inventions and patents
Brazil and China sign PPH agreement
17 November 2017 | Beijing | Reporter: Barney Dixon
The State Intellectual Property Office of China has signed a patent prosecution highway agreement with the Brazilian National Institution of Intellectual Property
Cozen O’Connor hires ex-DLA Piper litigator
17 November 2017 | Washington DC | Reporter: Barney Dixon
Cozen O’Connor has hired ex-DLA Piper litigator Hugh Marbury as member in its intellectual property department
Mewburn Ellis opens Munich office
16 November 2017 | Munich | Reporter: Barney Dixon
Intellectual property boutique Mewburn Ellis has opened a new office in Munich, its first expansion outside of the UK
EPO faces backlash over scrapping of permanent employment contracts
15 November 2017 | Munich | Reporter: Barney Dixon
In an internal memo, the Staff Union of the European Patent Office described the move as “Kafkaesque”